Announcing the death of 6 people who participated in the Pfizer...

Announcing the death of 6 people who participated in the Pfizer...
Announcing the death of 6 people who participated in the Pfizer...
A report issued by the US Food and Drug Administration stated that six people have died during trials of a Corona virus vaccine developed by the US pharmaceutical giant Pfizer and the German company Biontech.

It was reported in details that four of the six deceased received a placebo, and two were inoculated with the real drug, according to what Russia Today reported.

It was also announced that one of the participants in the vaccine test group had obesity and atherosclerosis, and died three days after taking the first dose of the drug.

The second volunteer had a heart attack 60 days after the second dose.

Of the participants who received the placebo vaccine, two died as a result of a heart attack and a stroke, while the cause of death of two others is being determined.

Of the six dead, three were over the age of 55.

In total, about 38,000 people over the age of 16 took the exams.

The US Food and Drug Administration had previously confirmed the effectiveness of the Pfizer and Biontech vaccine. The documents said that the drug showed an adequate level of safety, and there were no obstacles to its use in emergency situations.

These were the details of the news Announcing the death of 6 people who participated in the Pfizer... for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at saudi24news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV Houthi attacks cut Suez Canal revenue by 40-50%: Egyptian President El-Sisi
NEXT US Fed holds key rate steady for fourth straight meeting